Artificial Intelligence-Enhanced Application of CRISPR-Cas13a for Cancer Gene Therapy: A Breakthrough Concept

Abstract

The promise of AI and CRISPR-Cas13a in cancer gene therapy is a harmony of development and hope. With the use of AI and CRISPR-Cas13a's molecular precision, as well as AI's computational power, cancer treatments may be administered with unprecedented precision and adaptability in the future.

Keywords

• Artificial intelligence
• Cancer
• CRISPR
• Genome
• Oncology

References

1. Roma-Rodrigues C, Rivas-Garaa L, Baptista PV, Fernandes AR. Gene therapy in cancer treatment: why go nano? Pharmaceutics 2020; 12(3): 233. google scholar
2. Rao K. CRISPR-Cas13 and its applications in human therapeutics. J High Sch Sci 2021; 5(4): 1-21. google scholar
3. Granados-Riveron JT, Aquino-Jarquin G. CRISPR-Cas13 precision transcriptome engineering in cancer. Cancer Res 2018; 78(15): 4107-13. google scholar
4. Gao J, Luo T, Lin N, Zhang S, Wang J. A new tool for CRISPR-Cas13a-based cancer gene therapy. Mol Ther Oncolytics 2020; 19: 79-92. google scholar